Siranuysh Grabska

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Infectious Diseases

Top Venues

medRxiv : the preprint server for health sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Tigran Makunts, Siranuysh Grabska, Hovakim Grabski, Ruben Abagyan
Co-occurring infections in cancer patients treated with checkpoint inhibitors significantly increase the risk of immune related adverse events. medRxiv : the preprint server for health sciences (2024)
Tigran Makunts, Siranuysh Grabska, Hovakim Grabski, Ruben Abagyan
Co-occurring infections in cancer patients treated with checkpoint inhibitors significantly increase the risk of immune related adverse events. medRxiv : the preprint server for health sciences (2024)
Tigran Makunts, Siranuysh Grabska, Hovakim Grabski, Ruben Abagyan
Co-occurring infections in cancer patients treated with checkpoint inhibitors significantly increase the risk of immune related adverse events. medRxiv : the preprint server for health sciences (2024)
Siranuysh Grabska, Hovakim Grabski, Tigran Makunts, Ruben Abagyan
Co-Occurring Infections in Cancer Patients Treated with Checkpoint Inhibitors Significantly Increase the Risk of Immune-Related Adverse Events. Cancers 16 (16) (2024)
Tigran Makunts, Siranuysh Grabska, Hovakim Grabski, Ruben Abagyan
Co-occurring infections in cancer patients treated with checkpoint inhibitors significantly increase the risk of immune related adverse events. medRxiv : the preprint server for health sciences (2024)
Siranuysh Grabska, Hovakim Grabski, Tigran Makunts, Ruben Abagyan
Co-Occurring Infections in Cancer Patients Treated with Checkpoint Inhibitors Significantly Increase the Risk of Immune-Related Adverse Events. Cancers 16 (16) (2024)